• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.

作者信息

Armesto Susana, González Vela Carmen, Sánchez Julia, Illaro Aitziber, Mayorga Jesús, López Sundh Ana E, Naharro Fernández Cristina, Palmou Natalia, Gómez-Fernández Cristina, González López Marcos A, González-Gay Miguel A

机构信息

Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Department of Pathology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

出版信息

Dermatol Ther. 2020 Nov;33(6):e14464. doi: 10.1111/dth.14464. Epub 2020 Nov 8.

DOI:10.1111/dth.14464
PMID:33112014
Abstract
摘要

相似文献

1
Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.在新冠疫情期间使用布罗达单抗、阿普斯特、甲氨蝶呤和泼尼松联合疗法治疗耐多药银屑病
Dermatol Ther. 2020 Nov;33(6):e14464. doi: 10.1111/dth.14464. Epub 2020 Nov 8.
2
Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice.在加拿大两家学术医院诊所和一家社区诊所的COVID-19大流行期间，患者驱动的阿普斯特停药情况
J Cutan Med Surg. 2020 Jul/Aug;24(4):418-419. doi: 10.1177/1203475420928382. Epub 2020 May 12.
3
COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast.对于接受阿普司特治疗的银屑病患者，新冠疫苗不会引发银屑病发作。
Clin Exp Dermatol. 2021 Oct;46(7):1344-1346. doi: 10.1111/ced.14723. Epub 2021 Jun 9.
4
Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis.阿普米拉斯与司库奇尤单抗联合治疗中重度、顽固性斑块状银屑病患者。
Clin Exp Dermatol. 2019 Oct;44(7):e243-e244. doi: 10.1111/ced.14000. Epub 2019 May 20.
5
Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.银屑病患者的机会性病毒感染：在新冠疫情时代阿普米拉斯更安全的选择。
Dermatol Ther. 2020 Jul;33(4):e13618. doi: 10.1111/dth.13618. Epub 2020 Jun 4.
6
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.患有少突胶质细胞瘤的红皮病型银屑病患者的COVID-19肺部感染：阿普米司特与重症监护管理的安全性和兼容性
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e376-e378. doi: 10.1111/jdv.16625. Epub 2020 Jun 4.
7
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic.司库奇尤单抗治疗银屑病有效性和安全性的多中心研究：意大利在新冠疫情期间的16周真实世界经验
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e169-e170. doi: 10.1111/jdv.17003. Epub 2020 Nov 8.
8
Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.阿普米拉斯与司库奇尤单抗联合治疗一名顽固性斑块状银屑病患者
J Drugs Dermatol. 2016 May 1;15(5):648-9.
9
SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone.接受生物疗法或阿普米拉斯治疗的银屑病患者的新型冠状病毒2型血清学研究：意大利疫情重灾区93例患者的研究
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e86-e88. doi: 10.1111/jdv.17721. Epub 2021 Oct 14.
10
Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis.甲氨蝶呤初治银屑病患者中，甲氨蝶呤与阿普米司特的疗效比较和应答者增量成本。
J Am Acad Dermatol. 2016 Oct;75(4):740-746. doi: 10.1016/j.jaad.2016.05.040. Epub 2016 Jul 28.

引用本文的文献

1
[Hidradenitis suppurativa, report with dual therapy: small molecules and biological therapy].[化脓性汗腺炎，小分子与生物疗法联合治疗的报告]
Rev Med Inst Mex Seguro Soc. 2025 Mar 3;63(2):e6596. doi: 10.5281/zenodo.14617170.
2
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action.二氢叶酸还原酶抑制剂对 SARS-CoV-2 表现出多效性的抗病毒活性：作用机制的见解。
Viruses. 2023 May 9;15(5):1128. doi: 10.3390/v15051128.
3
Interleukin-17 Inhibitor Combination Therapies for the Treatment of Psoriasis: A Systematic Review.
用于治疗银屑病的白细胞介素-17抑制剂联合疗法：一项系统评价
J Clin Aesthet Dermatol. 2022 Jun;15(6 Suppl 1):S19-S31.
4
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review.阿普米司特联合生物制剂治疗银屑病：系统评价。
Am J Clin Dermatol. 2022 Sep;23(5):605-613. doi: 10.1007/s40257-022-00703-1. Epub 2022 Jun 23.
5
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios.阿普米拉斯在银屑病治疗中的应用：印度对现实世界情况的看法。
Psoriasis (Auckl). 2021 Aug 14;11:109-122. doi: 10.2147/PTT.S320810. eCollection 2021.